Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$72.15BHealthcare Market cap, Sector
Mega Lifesciences Public Company Limited
MEGA.BK$32.48BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 MEGA.BK
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsMEGA.BK
84B
C62
87A
C65
92A
F41
66C
F18
75B
F35
91A
D55
95A
D55
Side-by-side metrics
| Metric | JSLL.NS | MEGA.BK |
|---|---|---|
| Market cap | Winner: $72.15B | $32.48B |
| P/E (TTM) | 33.3x | 15.6x Winner |
| EV/EBIT | 24.1x | 10.7x Winner |
| ROIC (TTM) | Winner: 39.15% | 18.05% |
| Gross margin | Winner: 88.58% | 52.19% |
| Net margin | Winner: 27.68% | 13.51% |
| Revenue CAGR 5y | Winner: 57.81% | -3.38% |
| EPS CAGR 5y | Winner: 86.67% | -5.16% |
| Debt / Equity | 0.3x | 0.1x Winner |
| Dividend yield | - | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- EPS CAGR 5y86.67%vs -5.16%+106%
- Revenue CAGR 5y57.81%vs -3.38%+106%
- Market cap$72.15Bvs $32.48B+55%
- ROIC (TTM)39.15%vs 18.05%+54%
MEGA.BK leads on
- Debt / Equity0.1xvs 0.3x+75%
- EV/EBIT10.7xvs 24.1x+56%
- P/E (TTM)15.6xvs 33.3x+53%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.